| Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease |
Globe Newswire |
05/21 |
18:00 |
| Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma |
Globe Newswire |
05/21 |
17:51 |
| Mountain America Credit Union Ranked Among USA Today’s Top 10 Workplaces for Third Consecutive Year |
Globe Newswire |
05/21 |
17:49 |
| Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026 |
Globe Newswire |
05/21 |
17:39 |
| Free speech or race-baiting? Tennessee shooting stirs debate over livestreamer's approach |
AP Online |
05/21 |
17:32 |
| Trump eases refrigerant rule in a bid to address surging grocery costs |
AP Online |
05/21 |
17:09 |
| The Trump administration expands its use of AI in the hunt for healthcare fraud |
AP Online |
05/21 |
17:09 |
| US stocks edge higher following the latest U-turn for oil prices |
AP Online |
05/21 |
17:08 |
| Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season |
Globe Newswire |
05/21 |
17:06 |
| Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026 |
Globe Newswire |
05/21 |
17:05 |
| Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology |
Globe Newswire |
05/21 |
17:05 |
| Dying star resembles a billowing crystal ball in new telescope photo |
AP Online |
05/21 |
17:02 |
| Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin |
Globe Newswire |
05/21 |
17:02 |
| Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis |
Globe Newswire |
05/21 |
17:01 |
| BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting |
Globe Newswire |
05/21 |
17:00 |
| Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC |
Globe Newswire |
05/21 |
17:00 |
| Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy |
Globe Newswire |
05/21 |
17:00 |
| TruGolf Reports First Quarter 2026 Results |
Globe Newswire |
05/21 |
17:00 |
| NVIDIA Announces Upcoming Events for Financial Community |
Globe Newswire |
05/21 |
17:00 |
| Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting |
Globe Newswire |
05/21 |
17:00 |
| Hub Group Declares Quarterly Dividend |
Globe Newswire |
05/21 |
16:35 |
| [Latest] Global Private 5G Network Market to Reach USD 312.2 Billion by 2035, Expanding at a 52.8% CAGR, Says Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
Globe Newswire |
05/21 |
16:30 |
| Hub Group Receives Expected Deficiency Notice from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q |
Globe Newswire |
05/21 |
16:30 |
| Trump calls off AI executive order over concern it could weaken US tech edge |
AP Online |
05/21 |
16:28 |
| OFA Group Transitions to U.S. Domestic Issuer Status; Reaffirms United States as the Center of Its Growth Strategy |
Globe Newswire |
05/21 |
16:28 |
